Tissue Regenix Group plc
TRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£392 | -£1,713 | -£2,188 | -£3,484 |
| Dep. & Amort. | £1,046 | £977 | £921 | £793 |
| Deferred Tax | £0 | £0 | -£2,592 | -£2,037 |
| Stock-Based Comp. | £363 | £342 | £249 | £110 |
| Change in WC | -£3,588 | -£239 | -£500 | -£340 |
| Other Non-Cash | £936 | £1,673 | £2,815 | £1,983 |
| Operating Cash Flow | -£1,635 | £1,040 | -£1,409 | -£2,445 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£3,299 | -£413 | -£885 | -£1,488 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£759 | -£424 | -£197 | -£556 |
| Investing Cash Flow | -£4,058 | -£837 | -£1,082 | -£2,044 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £4,253 | -£238 | £1,387 | £438 |
| Stock Issued | £104 | £74 | £9 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1,078 | -£1,348 | -£486 | -£630 |
| Financing Cash Flow | £3,279 | -£1,512 | £910 | -£192 |
| Forex Effect | -£21 | £10 | -£294 | -£48 |
| Net Chg. in Cash | -£2,435 | -£1,299 | -£1,760 | -£5,259 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £4,650 | £5,949 | £5,692 | £9,550 |
| End Cash | £2,215 | £4,650 | £4,946 | £5,692 |
| Free Cash Flow | -£5,704 | £177 | -£2,294 | -£3,934 |